DPP-4 Inhibitors in Combination with Lipid-Lowering Agents and Risk of Serious Muscular Injury: A Nested Case-Control Study in a Nationwide Cohort of Patients with Type 2 Diabetes Mellitus.

Pariente, Antoine

DPP-4 Inhibitors in Combination with Lipid-Lowering Agents and Risk of Serious Muscular Injury: A Nested Case-Control Study in a Nationwide Cohort of Patients with Type 2 Diabetes Mellitus. [electronic resource] - Drug safety 08 2020 - 767-774 p. digital

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

1179-1942

10.1007/s40264-020-00936-1 doi


Aged
Aged, 80 and over
Case-Control Studies
Cohort Studies
Diabetes Mellitus, Type 2--complications
Dipeptidyl-Peptidase IV Inhibitors--adverse effects
Female
Fibric Acids--adverse effects
Follow-Up Studies
France--epidemiology
Hospitalization--statistics & numerical data
Humans
Hydroxymethylglutaryl-CoA Reductase Inhibitors--adverse effects
Hypolipidemic Agents--adverse effects
Male
Middle Aged
Muscular Diseases--chemically induced
Rhabdomyolysis--chemically induced
Risk Assessment